Overview

The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships to key regulatory and clinical considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.

Bringing together key stakeholders from the drug/device and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.

Need approval in order to attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.

Check out our 2019 Program!

Why Attend?

Featured

Want to learn more about DIA Annual Canadian Meeting? You've come to the right site!

Who should attend?

Professionals in pharmaceutical and device industries, regulatory agencies, and academia involved in:

Clinical data management/eClinical
Comparative effectiveness/health technology assessment
Clinical safety/pharmacovigilance
Clinical research
Document management/eSubmissions
Medical communications
Outsourcing
Project management
Public policy/law/corporate compliance
Quality assurance control
Regulatory affairs
Research and development
Statistics

Learning objectives

At the end of this session, participants should be able to:

Describe the current and evolving regulatory environment in Canada
Summarize current methods used in clinical trials, patient engagement, and improving market access
Discuss approaches on international harmonization, work sharing, and implementation of current guidelines
Review the various levels of transparency needed to maintain compliance in pre- and post-market activities

Program Committee

Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada
Lisa Chartrand Director, Regulatory Strategy and Policy
Hoffmann-La Roche Limited, Canada
Loretta Del Bosco Director, Regulatory Affairs Quality Assurance Operations
AbbVie Corporation, Canada
Fiona M Frappier, PhD Senior Policy Analyst
Health Canada, Canada
Lorella Garofalo, PhD Head of Regulatory Sciences
Pfizer Canada, Canada
Melissa Hunt, MSc Director
Health Canada, Canada
Yatika Kohli, PhD, MBA Chief Regulatory and Strategy Officer
NoNO Inc, Canada
Rania Mouchantaf, PhD A/Executive Director, Marketed Pharmaceuticals Bureau, MHPD
Health Canada, Canada
Kristin Willemsen, MS Vice President, Scientific & Regulatory Affairs
Food, Health & Consumer Products of Canada, Canada

Digital Learning Catalog

Download

Have an account?